Authors: Rittershaus, CW Miller, DP Thomas, LJ Picard, MD Honan, CM Emmett, CD Pettey, CL Adari, H Hammond, RA Beattie, DT Callow, AD Marsh, HC Ryan, US

Citation: Cw. Rittershaus et al., Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aorticlesions in a rabbit model of atherosclerosis, ART THROM V, 20(9), 2000, pp. 2106-2112

Authors: Picard, MD Pettey, CL Marsh, HC Thomas, LJ

Citation: Md. Picard et al., Characterization of N-linked oligosaccharides bearing sialyl Lewis x moieties on an alternatively glycosylated form of soluble complement receptor type I (sCRI), BIOT APP B, 31, 2000, pp. 5-13

Authors: Huang, J Kim, LJ Mealey, R Marsh, HC Zhang, Y Tenner, AJ Connolly, ES Pinsky, DJ

Citation: J. Huang et al., Neuronal protection in stroke by an sLe(x)-glycosylated complement inhibitory protein, SCIENCE, 285(5427), 1999, pp. 595-599

Authors: Wagner, E Platt, JL Howell, DN Marsh, HC Frank, MM

Citation: E. Wagner et al., IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model, J IMMUNOL, 163(6), 1999, pp. 3549-3558

Authors: Rittershaus, CW Thomas, LJ Miller, DP Picard, MD Geoghegan-Barek, KM Scesney, SM Henry, LD Sen, AC Bertino, AM Hannig, G Adari, H Mealey, RA Gosselin, ML Couto, M Hayman, EG Levin, JL Reinhold, VN Marsh, HC

Citation: Cw. Rittershaus et al., Recombinant glycoproteins that inhibit complement activation and also bindthe selectin adhesion molecules, J BIOL CHEM, 274(16), 1999, pp. 11237-11244

Authors: Zacharowski, K Otto, M Hafner, G Marsh, HC Thiemermann, C

Citation: K. Zacharowski et al., Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x, BR J PHARM, 128(5), 1999, pp. 945-952